ASSET PURCHASE AGREEMENTAsset Purchase Agreement • November 1st, 2013 • Oxygen Biotherapeutics, Inc. • Services-commercial physical & biological research • Delaware
THIS ASSET PURCHASE AGREEMENT (this “Agreement”), dated as of October 21, 2013, is by and among Oxygen Biotherapeutics, Inc., a Delaware corporation (“Parent”), Life Newco, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Purchaser”), Phyxius Pharma, Inc., a Delaware corporation (the “Company”), and Douglas Hay, John Kelley, Doug Randall and Stefan Stanko, the stockholders of the Company (collectively, the “Company Stockholders”). Parent, Purchaser, the Company and the Company Stockholders are referred to individually as a “Party” and, collectively, as the “Parties.”
